Hinge Health, Inc.
HNGE
Positions held
Your positionsHNGE isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Hinge Health operates in the rapidly growing health information services industry, focusing on digital health solutions that address musculoskeletal conditions, which are a leading cause of disability and healthcare cost
- Revenue increased by 17% compared to the prior quarter, reaching $213 million.
- The gross margin improved to 86.4%, up from 84.6% in the previous quarter.
- Despite growth, Hinge Health has faced significant operating losses, with an operating margin of -44.6% in 2023.
- The company reported a net income loss of $108.141 million in 2023, indicating ongoing financial challenges.
- The debt-to-equity ratio stands at 1.709, suggesting a reliance on debt financing which could pose risks in a rising interest rate environment.
Fundamentals
| Market cap | $7.91B | Enterprise value | $7.52B | Trailing P/E | 32.34 | Forward P/E | 32.05 |
| PEG | — | Price / book | 22.83 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 53.0% | Earnings growth | — | Gross margin | 84.5% | Operating margin | 19.0% |
| Profit margin | 15.1% | ROE | 30.4% | ROA | 7.7% | Debt / equity | 0.02 |
| Current ratio | 1.34 | Free cash flow | $299.65M | Analyst recommendation | buy | Mean target | $110.56 |
| 52w high | $100.36 | 52w low | $30.08 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $213M | $182M | $171M | $154M | $139M |
| Op margin | 19.0% | 17.6% | 16.0% | -4.0% | -417.5% |
| Net income | $43.7M | $35.1M | $32.1M | -$1.8M | -$576M |
| Gross margin | 86.4% | 84.6% | 84.4% | 81.8% | 70.3% |
| Gross profit | $184M | $154M | $144M | $126M | $97.8M |
| Operating income | $40.4M | $32.1M | $27.3M | -$6.1M | -$581M |
- Revenue +17% vs prior quarter ($213M vs $182M).
- Gross margin 86.4% (was 84.6% prior quarter).
- Operating margin expanded to 19%.
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $588M | $390M | $293M |
| Op margin | -92.9% | -8.2% | -44.6% |
| Net income | -$528M | -$11.9M | -$108M |
| Gross margin | 79.6% | 76.8% | 66.3% |
| Gross profit | $468M | $300M | $194M |
| Operating income | -$546M | -$31.9M | -$131M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · Hinge Health to announce third quarter 2026 financial results on November 2, 2026
2026-10-02 · These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
2026-10-01 · The 25-Year Stock Market Supercycle: Why The Biggest Acceleration Phase Is Still Ahead
2026-09-29 · Hinge Health Growth Outlook Supported by Member Gains, New Products, BofA Says
2026-09-29 · Netflix upgraded, PepsiCo downgraded: Wall Street's top analyst calls
2026-09-23 · Hinge Health Insider Sold Shares Worth $3,106,504, According to a Recent SEC Filing
2026-09-23 · Exceptional Earnings and AI Immunity Fuel Hinge Health’s (HNGE) Performance
2026-09-21 · Reasons to Hold Hinge Health Stock in Your Portfolio for Now
2026-09-19 · Is Hinge Health (HNGE) Still Undervalued As Its Digital Care Growth Draws Attention?
2026-09-18 · Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)
2026-09-16 · Dow Jones Futures Rise As Oil Prices, Yields Fall Before Fed Rate Hike; Will Market Rally Bid Bond Voyage?
2026-09-16 · Hinge Health Insider Sold Shares Worth $13,982,810, According to a Recent SEC Filing
Price (daily)
Full chart · RSI · MACD · patterns